Multi-analyte screening panels are redefining toxicology drug screening, enabling labs to detect dozens of substances—including drugs, environmental toxins, and even biomarkers of organ damage—in a single test. These panels are replacing traditional single-target tests, offering efficiency, cost savings, and deeper insights into patient or sample profiles. For pharmaceutical firms,...